Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox

Detalles Bibliográficos
Autores principales: Javanmard, Shaghayegh Haghjooy, Heshmat-Ghahdarijani, Kiyan, Vaseghi, Golnaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235302/
https://www.ncbi.nlm.nih.gov/pubmed/32362297
http://dx.doi.org/10.1017/ice.2020.195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235302/
https://www.ncbi.nlm.nih.gov/pubmed/32362297
http://dx.doi.org/10.1017/ice.2020.195

Ejemplares similares